Market Place
Sourcing Support
Adcendo Announces FDA Clearance For ADCE-D01 ADCElerate-01 Trial
08 Oct 2024 //
PR NEWSWIRE
Adcendo And Multitude Therapeutics Partner On First-In-Class ADC
20 Aug 2024 //
PR NEWSWIRE
Adcendo Extends Series A To EUR 98M For ADC Pipeline
30 May 2024 //
PR NEWSWIRE
Adcendo to Present Data on its Novel ADC Target uPARAP at the AACR Meeting 2024
04 Apr 2024 //
PR NEWSWIRE
Adcendo, Duality Biologics to Further Expand First-in-Class ADC Pipeline
01 Jun 2023 //
CONTRACT PHARMA
Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP
13 Apr 2023 //
PR NEWSWIRE
Adcendo Announces Extension of Series A Financing to 82M EUR
04 Apr 2023 //
PR NEWSWIRE
ADC biotech brings total Series A raise to $89M+; Takeda hands $40M to Arrowhead
04 Apr 2023 //
ENDPTS
Adcendo Announces Agreement with Duality Biologics on ADC Platform
05 Jan 2023 //
PR NEWSWIRE
Adcendo presents Data on uPARAP targeting ADCs in Osteosarcoma PDX Models
11 Apr 2022 //
PRNEWSWIRE
GSK oncology head leaves for biotech Scorpion—Chutes & Ladders
09 Jul 2021 //
FIERCEBIOTECH
Ex-Immunomedics CEO takes the wheel at Danish ADC player
07 Jul 2021 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.